Boenning & Scattergood’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | $13.1M | Buy |
80,679
+11,394
| +16% | +$1.85M | 2.1% | 4 |
|
|
2022
Q3 | $9.3M | Sell |
69,285
-9,715
| -12% | -$1.3M | 1.9% | 6 |
|
|
2022
Q2 | $12.1M | Sell |
79,000
-1,679
| -2% | -$257K | 2.29% | 4 |
|
|
2022
Q1 | $13.1M | Sell |
80,679
-774
| -1% | -$125K | 2.1% | 4 |
|
|
2021
Q4 | $11M | Sell |
81,453
-1,511
| -2% | -$205K | 1.76% | 6 |
|
|
2021
Q3 | $8.95M | Sell |
82,964
-3,991
| -5% | -$430K | 1.57% | 8 |
|
|
2021
Q2 | $9.8M | Buy |
86,955
+3,100
| +4% | +$349K | 1.71% | 8 |
|
|
2021
Q1 | $9.08M | Buy |
83,855
+5,253
| +7% | +$568K | 1.73% | 7 |
|
|
2020
Q4 | $8.42M | Sell |
78,602
-286
| -0.4% | -$30.6K | 1.78% | 7 |
|
|
2020
Q3 | $6.91M | Buy |
78,888
+152
| +0.2% | +$13.3K | 1.66% | 8 |
|
|
2020
Q2 | $7.73M | Buy |
78,736
+1,201
| +2% | +$118K | 2.06% | 5 |
|
|
2020
Q1 | $5.91M | Sell |
77,535
-1,059
| -1% | -$80.7K | 2.04% | 6 |
|
|
2019
Q4 | $6.96M | Buy |
78,594
+4,919
| +7% | +$436K | 1.79% | 9 |
|
|
2019
Q3 | $5.58M | Buy |
73,675
+9,858
| +15% | +$746K | 1.61% | 10 |
|
|
2019
Q2 | $4.64M | Buy |
63,817
+2,349
| +4% | +$171K | 1.36% | 12 |
|
|
2019
Q1 | $4.95M | Buy |
61,468
+15,857
| +35% | +$1.28M | 1.48% | 11 |
|
|
2018
Q4 | $4.21M | Sell |
45,611
-220
| -0.5% | -$20.3K | 1.47% | 11 |
|
|
2018
Q3 | $4.34M | Sell |
45,831
-2,181
| -5% | -$206K | 1.38% | 11 |
|
|
2018
Q2 | $4.45M | Buy |
+48,012
| New | +$4.45M | 1.46% | 11 |
|